Therapeutic Specialties Archives | 第 7 页，共 27 页 | Certara

Publication

Quantitative Systems Pharmacology approaches for immuno‐oncology: adding virtual patients to the development paradigm

Drug development in oncology commonly exploits the tools of molecular biology to gain therapeutic benefit…

Jieun Choe2020 年 7 月 26 日

Blog

The Research to Accelerate Cures and Equity (RACE) for Children Act: Changing the Landscape of Pediatric Cancer Drug Development

3 key tips to set your pediatric program up for success with the RACE for…

Certara2020 年 7 月 14 日

Publication

Mechanistic quantitative pharmacology strategies for the early clinical development of bispecific antibodies in oncology

Bispecific antibodies (bsAbs) have become an integral component of the therapeutic research strategy to treat…

Jieun Choe2020 年 7 月 14 日

Blog

Local Therapies for the Global COVID-19 Pandemic

Henri Merdjan explains why topical drug formulations (e.g. intranasal and/or oral) could be valuable as…

Certara2020 年 5 月 29 日

Blog

Applying decision analysis to drug development for COVID-19 & future pandemics

This blog discusses how decision analysis approaches can help drug developers to better decisions under…

Certara2020 年 4 月 30 日

网络研讨会点播

罕见病药物困境：价值大、价格高、准入受限？

This webinar will explain how pricing has evolved for the rare disease drug market and…

Danielle Pillsbury2020 年 2 月 19 日

Publication

Use of Modeling and Simulations to Determine Raltegravir Dosing in Neonates: A Model for Safely and Efficiently Determining Appropriate Neonatal Dosing Regimens: IMPAACT P1110

Danielle Pillsbury2020 年 1 月 17 日

Publication

Maternal-Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing

Maternal-Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing

Danielle Pillsbury2020 年 1 月 17 日

On-Demand Webinar

快速跟踪罕见病药物的创新解决方案

This webinar discussed which pharmaceutical payer strategies work and which don't in our rapidly changing…

Danielle Pillsbury2019 年 8 月 10 日

Poster

Pharmacodynamics of rituximab on B cells in paediatric post-HSCT patients with EBV

Danielle Pillsbury2019 年 6 月 24 日

© 2025 Certara. 保留所有权力。 | 隐私政策

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software